G1 Therapeutics, Inc. short interest in 2019

In 2019, G1 Therapeutics, Inc.'s disclosed short interest ran from 12.67% of shares outstanding on 15 Oct 2019 to 10.85% on 31 Dec 2019, a change of -1.82 percentage points. The year's high was 13.99% on 31 Oct 2019 and its low 10.85% on 31 Dec 2019, averaging 12.81% across 6 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 24.88 days on 15 Nov 2019. Full history: G1 Therapeutics, Inc..

Cite this page

Plain

Short position data for G1 Therapeutics, Inc. short interest in 2019: FINRA, compiled by howshorted.com, settlement date 31 Dec 2019. https://howshorted.com/us/company/gthx-2024/2019/

Wikipedia

<ref>{{cite web |title=G1 Therapeutics, Inc. short interest in 2019 short position data |url=https://howshorted.com/us/company/gthx-2024/2019/ |website=HowShorted |publisher=howshorted.com (data: FINRA) |date=2019-12-31 |access-date=2026-10-13}}</ref>

BibTeX

@misc{howshorted-g1-therapeutics-inc-short-interest-in-20-2019-12-31,
  title        = {G1 Therapeutics, Inc. short interest in 2019 short position data},
  author       = {{HowShorted}},
  howpublished = {\url{https://howshorted.com/us/company/gthx-2024/2019/}},
  note         = {Data: FINRA, settlement date 31 Dec 2019; accessed 2026-10-13},
  year         = {2019}
}

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024

2019 in figures

Start of year: 12.67% (15 Oct 2019)
End of year: 10.85% (31 Dec 2019)
Change: -1.82 pp
High: 13.99% (31 Oct 2019)
Low: 10.85% (31 Dec 2019)
Average: 12.81%
Highest days to cover: 24.88 (15 Nov 2019)
SEC filings marked: 8

Every report in 2019

G1 Therapeutics, Inc. short interest in 2019
Settlement	Short interest	Days to cover	Filings since previous
15 Oct 2019	12.67%	8.68	10-K filed, results (8-K), 10-Q filed, results (8-K), 10-Q filed, results (8-K)
31 Oct 2019	13.99%	17.06
15 Nov 2019	13.96%	24.88	10-Q filed, results (8-K)
29 Nov 2019	12.77%	16.81
13 Dec 2019	12.60%	12.71
31 Dec 2019	10.85%	9.83

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.